Atlas Trials

Adding Evolocumab to Conventional Lipid-lowering Therapy for Hypertriglyceridemia Induced Acute Pancreatitis

Clinical trial NCT07388420 · RECRUITING

Trial details

NCT number
NCT07388420
Sponsor
General Hospital of Shenyang Military Region
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Hypertriglyceridemia Induced Acute Pancreatitis
Start date
2026-01-02
Primary completion
2026-12-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.